ChemoMetec Statistics
Total Valuation
ChemoMetec has a market cap or net worth of DKK 6.52 billion. The enterprise value is 6.29 billion.
Market Cap | 6.52B |
Enterprise Value | 6.29B |
Important Dates
The next estimated earnings date is Wednesday, September 11, 2024.
Earnings Date | Sep 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ChemoMetec has 17.40 million shares outstanding. The number of shares has increased by 0.04% in one year.
Shares Outstanding | 17.40M |
Shares Change (YoY) | +0.04% |
Shares Change (QoQ) | +0.07% |
Owned by Insiders (%) | 0.30% |
Owned by Institutions (%) | 51.53% |
Float | 17.35M |
Valuation Ratios
The trailing PE ratio is 45.37 and the forward PE ratio is 44.33. ChemoMetec's PEG ratio is 3.17.
PE Ratio | 45.37 |
Forward PE | 44.33 |
PS Ratio | 16.25 |
PB Ratio | 13.07 |
P/FCF Ratio | 49.40 |
PEG Ratio | 3.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.74, with an EV/FCF ratio of 47.69.
EV / Earnings | 43.76 |
EV / Sales | 15.67 |
EV / EBITDA | 32.74 |
EV / EBIT | 34.87 |
EV / FCF | 47.69 |
Financial Position
The company has a current ratio of 4.68, with a Debt / Equity ratio of 1.19.
Current Ratio | 4.68 |
Quick Ratio | 3.33 |
Debt / Equity | 1.19 |
Debt / EBITDA | 0.03 |
Debt / FCF | 0.05 |
Interest Coverage | 89.42 |
Financial Efficiency
Return on equity (ROE) is 30.09% and return on invested capital (ROIC) is 23.26%.
Return on Equity (ROE) | 30.09% |
Return on Assets (ROA) | 19.61% |
Return on Capital (ROIC) | 23.26% |
Revenue Per Employee | 2.35M |
Profits Per Employee | 840,936 |
Employee Count | 167 |
Asset Turnover | 0.70 |
Inventory Turnover | 0.45 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.02% in the last 52 weeks. The beta is 1.33, so ChemoMetec's price volatility has been higher than the market average.
Beta (5Y) | 1.33 |
52-Week Price Change | -11.02% |
50-Day Moving Average | 367.10 |
200-Day Moving Average | 375.15 |
Relative Strength Index (RSI) | 48.97 |
Average Volume (20 Days) | 29,911 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ChemoMetec had revenue of DKK 401.54 million and earned 143.80 million in profits. Earnings per share was 8.26.
Revenue | 401.54M |
Gross Profit | 354.11M |
Operating Income | 180.44M |
Pretax Income | 183.43M |
Net Income | 143.80M |
EBITDA | 192.20M |
EBIT | 180.44M |
Earnings Per Share (EPS) | 8.26 |
Balance Sheet
The company has 232.15 million in cash and 5.95 million in debt, giving a net cash position of 226.20 million or 13.00 per share.
Cash & Cash Equivalents | 232.15M |
Total Debt | 5.95M |
Net Cash | 226.20M |
Net Cash Per Share | 13.00 |
Equity (Book Value) | 498.73M |
Book Value Per Share | 28.66 |
Working Capital | 330.73M |
Cash Flow
In the last 12 months, operating cash flow was 146.71 million and capital expenditures -14.76 million, giving a free cash flow of 131.96 million.
Operating Cash Flow | 146.71M |
Capital Expenditures | -14.76M |
Free Cash Flow | 131.96M |
FCF Per Share | 7.58 |
Margins
Gross margin is 88.19%, with operating and profit margins of 44.94% and 35.81%.
Gross Margin | 88.19% |
Operating Margin | 44.94% |
Pretax Margin | 45.68% |
Profit Margin | 35.81% |
EBITDA Margin | 47.87% |
EBIT Margin | 44.94% |
FCF Margin | 32.86% |
Dividends & Yields
This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 1.58%.
Dividend Per Share | 6.00 |
Dividend Yield | 1.58% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | 72.61% |
Buyback Yield | -0.04% |
Shareholder Yield | 1.54% |
Earnings Yield | 2.20% |
FCF Yield | 2.02% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |